Menu Search
Equities

Bastide le Confort Medical SA

0IP1:LSE

Bastide le Confort Medical SA

Actions
  • Price (EUR)18.34
  • Today's Change0.00 / 0.00%
  • Shares traded16.00
  • 1 Year change-35.76%
  • Beta--
Data delayed at least 20 minutes, as of May 03 2024 08:48 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bastide le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for elderly, sick or handicapped people, for healthcare professionals and individual clients. The Company’s product and services are divided into three divisions: home care equipment and services like wheelchairs, ergonomic pillows, anti-bedsore supports, self-diagnostic equipment and personal assistance products; perfusion and nutrition equipment and services like perfusion instruments, insulin pumps and syringe-drivers and respiratory assistance equipment and services like respirators, oxygen concentrators and oxygen tanks. In addition, the Company is involved in the rental and maintenance of medical equipment, such as insulin pumps, ventilators and nutrition check instruments. It operates through Societe S'Care Assistance, Bordo2 Medica, Medsoft, ATS Rhone Alpes SARL, tCM Pharma and Air+ Sante.

  • Revenue in EUR (TTM)523.32m
  • Net income in EUR6.32m
  • Incorporated1976
  • Employees3.55k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		BLC:PAR since
announced		Transaction
value
OxigoDeal completed01 Jul 202301 Jul 2023Deal completed-35.45%--
Occit PerfDeal completed01 Jul 202301 Jul 2023Deal completed-35.45%--
Data delayed at least 15 minutes, as of May 03 2024 16:35 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.